Brain Tumor Treatment Satisfaction Survey
Treatment Satisfaction Survey for Brain Tumor Patients and Their Caregivers
1 other identifier
observational
105
1 country
1
Brief Summary
Patients with recent diagnosis and treatment of a brain tumor will complete a short questionnaire concerning the patient's quality of life and emotional state since receiving treatment. Caregivers will complete a one-page questionnaire concerning the patient's quality of life and emotional state since receiving treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2007
CompletedFirst Submitted
Initial submission to the registry
November 13, 2007
CompletedFirst Posted
Study publicly available on registry
November 14, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2009
CompletedApril 11, 2022
April 1, 2022
1.8 years
November 13, 2007
April 4, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall satisfaction and emotional impact of treatments in patients who have undergone therapy(s)for brain tumors.
(greater than or equal to 3 months) from first treatment for brain tumor
Secondary Outcomes (1)
Observational data about the treatment course and emotional well-being of the brain tumor patient as provided by the caregiver.
(Greater than or equal to 3 months) from first treatment for brain tumor
Study Arms (2)
1
Brain tumor patients
2
Caregivers of brain tumor patients
Eligibility Criteria
Brain tumor patients and their caregivers
You may qualify if:
- Patients who are between 3 months and one year out from treatment for their brain tumor
- Karnofsky Performance Status (KPS) \>= 60
- Age 18 years or over, any gender, any race
- "patient caregivers will be individuals who provide the most day-to-day care for their respective brain tumor patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Methodist University Hospital
Memphis, Tennessee, 38104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeffrey M. Sorenson, MD
Methodist Healthcare
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 13, 2007
First Posted
November 14, 2007
Study Start
June 1, 2007
Primary Completion
March 1, 2009
Study Completion
March 1, 2009
Last Updated
April 11, 2022
Record last verified: 2022-04